Please contact your health insurance company to confirm provider participation. For billing and insurance questions, please call our Billing Department at 210-358-3260.
About
Olga Lavrynenko, MD
"From caring for patients with metabolic disorders in Ukraine to serving underserved communities in Laredo, Texas, and completing my endocrinology fellowship at Harvard - I am dedicated to helping patients manage diabetes, MASLD and cardiovascular disease by turning research into real improvements in their lives."
I am an endocrinologist specializing in diabetes and metabolic disease. I was inspired to go into medicine by my mother, who was a physician, along with my lifelong fascination with science. Above all, I am driven by a genuine desire to help people improve their health and quality of life.
My philosophy of care is rooted in the belief that everyone deserves compassionate accessible and personalized medical support.
I view health improvement as a shared effort, partnering closely with patients to create sustainable treatment plans that reflect their individual needs and goals.
Favorite Parts of Medicine
Seeing patients recover as they make meaningful improvements in their health
Working collaboratively with patients to manage complex metabolic conditions
Third Place, Oral Presentation - World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (Los Angeles, 2023)
New England Endocrine Alliance Fellow Podium/Poster Award (Boston, 2023)
Second Place, Oral Presentation - Heart in Diabetes (New York City, 2021)
Third Place, Oral Presentation - World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (Los Angeles, 2021)
Conference Award, European Association for the Study of the Liver (Vienna, 2010)
Honorable Mention, Oral Presentation - Heart in Diabetes (Philadelphia, 2019)
Honorable Mention, Oral Presentation - World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (Los Angeles, 2019)
Hobbies
Outside of medicine, I enjoy traveling, reading, playing golf and staying active through Zumba and Pilates.
Articles & Publications
Journal Articles
Lavynenko O, Abdul-Ghani M, DeFronzo RA. Reduced Lipotoxicity Following Triple Therapy for 3 Years in New
Onset T2DM: Metabolism. Volume 153, Supplement, June 2024, 155851.
Lavrynenko O., Baireddy M., Bodepudi S.,Santos H, Cortez J., Zemlianitsyna O,
Sanchez F. Peritoneal and Pulmonary Tuberculosis in a Postpartum Female with Elevated Cancer Antigen 125 and
Ascites. Case Rep Infec Dis 2022 Oct 26: 2022: 7012943. doi: 10.1155/2022/7012943.eCollection 2022.
Lavrynenko O., Abdul-Ghani M., Alatrach M., Puckett C., Adams J., Abdelgani S., Alkhouri N., Triplitt C., Clarke G.,
Vasquez J., Cersosimo E., gastadelli A., DeFronzo R. Combination therapy with pioglitazone/exenatide/metformin
reduces the prevalence of hepatic fibrosis and steatosis: The efficacy and durability of initial combination therapy for
type 2 diabetes (EDICT). Diabetes, Obesity and Metabolism, May 2022, Volume 24, Issue 5, p.897-907
https://doi.org/10.1111/dom.14650.
Lavrynenko O., Abdul-Ghani M, Santos H., DeFronzo R. Hepatic steatosis, fibrosis, and insulin resistance:
implications for therapy. Metabolism Clinical and Experimental. 2022, March, Vol 128, supplemental 155018.
https://doi.org/10.1016/j.metabol.2021.155018.
Villafuerte D., Lavrynenko O., Qazi R., Passeri M., Sanchez F. Chronic active Epstein-Barr exacerbated by
COVID-19 co-infection. International Journal of Infectious diseases. 2022; 122 ; 976-978.
Lavrynenko O., Abdul-Ghani M, DeFronzo R. Carotid Atherosclerosis Is Not Related to Hepatic Steatosis or
Fibrosis in EDICT. AHJ, Vol 242, 2021. p.152, https://doi.org/10.1016/j.ahj.2021.10.019.
Lavrynenko O., Santos H., Garza A., Qazi R., Cobos L. Euglycemic Diabetic ketoacidosis in a Diabetic Patient
Treated with SGLT2 Inhibitor. Austin Endocrinol Diabetes case Rep. 2021; 6(1): 1018.
Lavrynenko O., Alatrach M., Abdul-Ghani M., Cersosimo E., Puckett C., Alkhouri N., DeFronzo R., Adams J.,
Vasquez J., Clarke G. Liver Fibrosis Scores Do Not Predict Response to Therapy in T2DM. Diabetes 2020
Jun; 69 (Supplement 1): 184-OR. https://doi.org/10.2337/db20-184-OR.
Call 210-358-7500 to request an appointment with this doctor.
